ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 031,08
0,43%
Dow Jones
38 852,27
0,46%
DAX
18 243,39
0,39%
Brent Oil
83,105
-0,44%
Bitcoin
63 710,72
0,86%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Enanta Pharmaceuticals Inc (ENTA)

  7. Enanta Pharmaceuticals Inc (ENTA) Actualités

ENTA Enanta Pharmaceuticals Inc

14,60
0,00 (0,00%)
07 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Enanta Pharmaceuticals Inc ENTA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 14,60 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
14,60
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/5/202422:05EDGAR2Form 8-K - Current report
06/5/202422:01BWEnanta Pharmaceuticals Reports Financial Results for its..
30/4/202413:10BWEnanta Pharmaceuticals Announces Inducement Grants Under..
30/4/202413:00BWEnanta Pharmaceuticals Announces the Appointment of Matthew..
29/4/202413:00BWEnanta Pharmaceuticals to Host Conference Call on May 6 at..
17/4/202413:00BWEnanta Pharmaceuticals Announces Data Presentation at ESCMID..
08/3/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202413:00BWEnanta Pharmaceuticals to Participate at Leerink Partners..
28/2/202400:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202419:11EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
15/2/202402:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202420:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/2/202422:05EDGAR2Form 8-K - Current report
07/2/202422:01BWEnanta Pharmaceuticals Reports Financial Results for its..
06/2/202413:00BWEnanta Pharmaceuticals to Participate at the Oppenheimer..
31/1/202413:00BWEnanta Pharmaceuticals to Host Conference Call on February 7..
26/1/202422:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/1/202422:25EDGAR2Form DEF 14A - Other definitive proxy statements
24/1/202423:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/1/202422:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/1/202413:00BWEnanta Pharmaceuticals to Provide Updates on its Research..
03/1/202413:00BWEnanta Pharmaceuticals to Present at the 42nd Annual J.P...
26/12/202322:06EDGAR2Form 8-K - Current report
16/12/202302:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202323:16EDGAR2Form 144 - Report of proposed sale of securities
07/12/202302:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202302:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202302:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202302:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202302:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202302:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202302:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202303:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202303:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202303:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202303:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202303:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202303:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
ENTA
Enanta Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés